ANTHELIOS SX
LOE Approachingavobenzone; ecamsule; octocrylene
NDATOPICALCREAM
Approved
Jul 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
ANTHELIOS SX (avobenzone; ecamsule; octocrylene). Approved for sunburns, wind burned, chapped lips. First approved in 2006.
Drug data last refreshed 5d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ANTHELIOS SX is a topical sunscreen cream combining avobenzone, ecamsule, and octocrylene to provide broad-spectrum UV protection. It is indicated for prevention and treatment of sunburns, wind-burned skin, and chapped lips. The product works through UV-absorbing chemical filters that convert solar radiation into harmless heat.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), signaling potential team restructuring and transition planning for brand defenders.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (3)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.